ASH 2022: CLL

Advertisement
Cailin ConnerASH Annual Meeting 2022 | May 2, 2023
Chronic lymphocytic leukemia (CLL), a cancer of the blood and bone marrow that progresses over time, is one of the most ...
Cailin ConnerASH Annual Meeting 2022 | May 2, 2023
Chronic lymphocytic leukemia (CLL) is a cancer of the blood and bone marrow that progresses over time. The number of ...
Cailin ConnerASH Annual Meeting 2022 | May 2, 2023
“Patients with chronic lymphocytic leukemia [CLL] have a higher risk of developing second primary malignancies ...
Cailin ConnerASH Annual Meeting 2022 | May 2, 2023
In patients with chronic lymphocytic leukemia (CLL), targeted therapies significantly improve clinical outcomes and ...
Cailin ConnerASH Annual Meeting 2022 | May 2, 2023
A research paper presented by Andrea Visentin, MD, PhD, of the University of Padova in Italy, and colleagues at the 64th ...
Advertisement